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Abstract
 
During variable/diversity/joining (V[D]J) recombination, the enzyme terminal deoxynucleoti-
dyl transferase (Tdt) adds random nucleotides at the junctions of the rearranging gene segments,
increasing diversity of the antibody (Ab) and T cell receptor repertoires. Two splice variants of
Tdt have been described, but only one (short isoform of Tdt [TdtS]) has been convincingly
demonstrated to catalyze nontemplated (N) addition in vitro. We have expressed each splice
variant of Tdt in transgenic (Tg) mice and found that the TdtS transgene catalyzes N addition
on the endogenous Tdt
 
2
 
/
 
2
 
 background and in fetal liver, but that the long isoform of Tdt
(TdtL) transgene does neither. In contrast to previous in vitro results, both TdtS and TdtL are
translocated to the nucleus in our model. Furthermore, TdtL/TdtS double Tg mice exhibit less
N addition in fetal liver than do TdtS Tg mice. Whereas the TdtS transgene was shown to
have functional consequences on the antiphosphorylcholine (PC) B cell repertoire, TdtL Tg
mice exhibit a normal PC response, and Tdt
 
2
 
/
 
2
 
 mice actually exhibit an increase in the PC re-
sponse and in TEPC 15 idiotype
 
1
 
 Ab production. We conclude that TdtL localizes to the nu-
cleus in vivo
 
 
 
where it serves to modulate TdtS function.
Key words: V(D)J rearrangements • terminal deoxynucleotidyl transferase • nontemplated 
regions • terminal deoxynucleotidyl transferase isoforms • phosphorylcholine
 
Introduction
 
Terminal deoxynucleotidyl transferase (Tdt)
 
1
 
 is a nuclear
enzyme that catalyzes addition of nontemplated (N) nucle-
 
otides to the free 3
 
9
 
-OH ends of fragmented or nicked
DNA (1). Thus far, the only known physiological function
of Tdt is the random addition of nucleotides to the V(D)J
junctions of Ig H chain and TCR gene rearrangements (2–6)
and, rarely, of Ig L chain rearrangements (7, 8). N addition
effectively increases diversity in the repertoire of Ig and
 
TCR receptors on lymphoid cells. In vitro
 
,
 
 the enzymatic
 
activity of Tdt can be measured in crude cell extracts (1, 9–11)
as well as in cellular recombination systems using trans-
fected Tdt and recombination substrates (12–14). Addition-
ally, Tdt activity has been shown to be associated with the
Ku protein (15), and to be altered by the DNA-dependent
protein kinase, of which Ku is a subunit (15, 16).
 
Two mRNA splice variants of Tdt have been described
in mice (17, 18). Koiwai et al. initially isolated and charac-
terized the first two murine Tdt cDNA clones (M11-3 and
M16-1b; reference 19). The complete sequence of clone
M11-3 was highly homologous to human and bovine Tdt
cDNAs except for a 60-bp insertion encoding a unique 20
amino acid (aa) region near the carboxy terminus. Later,
Doyen et al. (18) cloned a second shorter isoform (TdtS)
from mice lacking this insertion, and for which the
mRNA is expressed at much higher levels than the long
form (TdtL). TdtL was also formally shown to contain a
20-aa insertion encoded by an additional exon “Xbis” lo-
cated between exons X and XI of the murine Tdt gene
(18). Although Tdt genes have since been identified and
cloned from many vertebrate species, TdtL has been de-
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Abbreviations used in this paper: 
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scription; T15, TEPC 15; Tdt, terminal deoxynucleotidyl transferase;
TdtL, long isoform of Tdt; TdtS, short isoform of Tdt; Tg, transgenic. 
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scribed only in mice (19–23). Two alternative insertions
have also been described for bovine Tdt, one of which
bears some similarity to the insertion found in murine
TdtL (24). Initially, Koiwai et al. (19) reported that a TdtL
clone, M16-1b, produced Tdt protein with enzymatic ac-
tivity in COS cells. The other clone, M11-3, was pre-
sumed to be neither expressed nor functional, because it
contained an additional 5
 
9
 
 out-of-frame ATG. Later, func-
tional N addition by TdtS was shown using an episomic
rearrangement construct in NIH 3T3 fibroblasts by Doyen
and colleagues (18). The 5
 
9
 
 out-of-frame ATG did not
cause aberrant translation in the latter experiments, perhaps
because the ATG lacks a favorable Kozak context (18).
These data together suggested that both Tdt isoforms are
functional. However, direct comparison of TdtS and TdtL
clones (one of the original Koiwai TdtL clones as well as
an independent TdtL clone) showed that TdtS added N
nucleotides much more efficiently than the two different
TdtL clones. The
 
 
 
observation that in NIH 3T3 and COS
transfectants, TdtS translocated to the nucleus whereas
TdtL remained in the cytoplasm and did not enter the nu-
cleus, was used to explain the difference in TdtS versus
TdtL activity in this assay (25). However, lysates from the
two TdtL COS cell transfectants contained 10–15 times
less terminal transferase activity than TdtS. TdtL protein
was also shown to be less stable than TdtS protein. Al-
though no direct comparisons have been made, this result
appears to contradict the original COS cell transfection
data with the Koiwai TdtL M16-1b clone. Functional
analysis of the two mouse Tdt isoforms has therefore pro-
duced contradictory and seemingly irreconcilable results.
At this point, it is difficult to draw any conclusions about
the function of TdtL, in contrast to TdtS, which is clearly
functional as a transgene in vivo (26, 27).
We chose to investigate the function of the TdtL iso-
form in vivo. This is quite difficult in normal mice because
they express both isoforms. Although it is relatively easy to
distinguish TdtL from TdtS mRNA, identifying the pro-
teins is more difficult. Anti-Tdt mAbs that discriminate be-
tween the two splice variants are not available and TdtS
and TdtL proteins, differing only slightly in size, are not
easily resolved on a standard protein analysis gel. Therefore,
to determine whether TdtL can catalyze N addition or
serve another function in vivo, we generated Tdt trans-
genic (Tg) mice in which a TdtL transgene was placed un-
der the control of the same IgH promoter and enhancer
used in our TdtS Tg mice that catalyzed N addition in both
fetal and adult B lineage cells (27). As expected, TdtL Tg
mRNA was detected in bone marrow, thymus, and spleen.
Although TdtL protein was detected in the nuclei of
mouse B cells, TdtL expression neither complemented the
N addition defect in adult bone marrow of Tdt-deficient
mice nor introduced N nucleotides into fetal/neonatal liver
Ig rearrangements. In contrast, Tg TdtS catalyzed N addi-
tion in adult bone marrow of endogenous Tdt-deficient
mice to the extent that H chain Ig rearrangements resem-
bled those of normal Tdt-sufficient mice. Notably, TdtL/
TdtS double Tg mice display a phenotype intermediate be-
tween TdtS or TdtL single Tgs, with respect to N addition.
7183 V
 
H
 
-D-J
 
H
 
 rearrangements display this phenotype, but
it is more strikingly revealed by D-J
 
H
 
 rearrangements am-
plified from day 16 fetal liver of TdtL/TdtS double Tg
mice. The observation of this intermediate phenotype in
double Tg mice derived from three independent TdtL lines
crossed with TdtS line V, the most effective adder of N nu-
cleotides, suggests that TdtL can downregulate TdtS-medi-
ated N addition. Biochemical studies addressing a possible
mechanism for this downregulation are currently in
progress. As a functional analysis to confirm the role of
TdtL in Ab repertoire formation, the antiphosphorylcho-
line (PC) response was induced by immunization with
 
Streptococcus pneumoniae
 
. In contrast to the loss of the domi-
nant canonical TEPC 15 (T15) Id normally encoded by
N-less CDR3 regions that occurs in TdtS Tg mice (27),
the T15 anti-PC immune response remains intact in TdtL
Tg and is elevated in Tdt knockout mice. Thus, TdtL must
serve a different function than its counterpart, TdtS. We
propose that TdtL may play a regulatory role in N addition
or V(D)J recombination.
 
Materials and Methods
 
TdtL Cloning.
 
All primers used for amplifying and sequenc-
ing the TdtS and TdtL forms were based on the sequence of a
mouse Tdt clone isolated from RL-12 lymphoma cells (C57Bl/
Ka) reported by Koiwai (19). All numbering is based on this se-
quence (sequence data are available from EMBL/GenBank/
DDBJ under accession no. X04123). Initially, a 1.9–2-kb Tdt
fragment was amplified from cDNA generated from C57Bl/6
(B6) thymus RNA using the following primers: 5
 
9
 
-GCTGATA-
CATTCTGGAGACACCACCTGATGG-3
 
9
 
 (includes 1–23)
and 5
 
9
 
-GGTGATCAGACACACAGGAGTCAGGTGGGC-3
 
9
 
(1947–1972). This fragment was blunt cloned into EcoRV-
digested pBluescript. One clone was sequenced (both strands)
from the 5
 
9
 
 end to 1,749 (
 
.
 
100 bp past the stop codon) using the
dideoxy chain termination method. All differences from the Koi-
wai sequence were confirmed in independent clones, by direct
sequencing of independently amplified PCR fragments and,
where possible, a genomic clone. This clone, the short form
(TdtS), was then truncated at the 5
 
9
 
 end to eliminate the first
(out-of-frame) ATG, leaving 17 bp 5
 
9
 
 to the appropriate ATG in
the final short form clone.
To generate the long form (TdtL), primers flanking the re-
gion 1351–1590, 5
 
9
 
-ACAGCGAGAAGAGCGGCCAGCAG-3
 
9
 
(1,298–1,320) and 5
 
9
 
-CCATGGTTCAATGTAGTCCAGTC-
3
 
9
 
 (1,604–1,626) were used to amplify B6 thymus cDNA. The
longer, much less abundant, of two fragments was isolated,
cloned, and sequenced. It contained a 60-bp insertion identical to
that published by Koiwai. To generate a long form, full-length
Tdt clone, a BglII
 
 
 
fragment (1,351–1,590) containing the long
form insertion was used to replace this region in the fully se-
quenced Tdt short form clone. All cloning junctions and the in-
sertion were confirmed by sequencing. For the full sequence of
our TdtL and TdtS clones, refer to EMBL/GenBank/DDBJ ac-
cession nos. AF316014 and AF316015, respectively.
 
Mice.
 
TdtL Tg mice were generated as described previously
using a plasmid construct containing the cDNA for TdtL, the
V
 
H
 
81X promoter, E
 
m
 
, and the EcoRI fragment of C
 
m
 
 (27). 10
founder lines were generated and bred onto the BALB/c back- 
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ground. Tg mice were identified by PCR and Southern blot as
described previously (27). To discriminate between the TdtL and
TdtS transgenes, PCR primer 1450Tdt (5
 
9
 
-GCTATGCCACA-
CACGAGAGGAAGAT-3
 
9
 
) was designed in the 10th exon of
Tdt, just upstream of the 60-bp insert in TdtL. When paired with
primer exJh3 (5
 
9
 
-CTGCAGAGACAGTGACCAGAGT-3
 
9
 
), lo-
cated in the J
 
H
 
3 exon downstream of the Tdt cDNA in the
trangene construct, 1450 Tdt gives a 520-bp product from the
TdtS trangene and a 580-bp product from the TdtL transgene
which can be easily resolved on a 3% MetaPhor agarose gel
(FMC BioProducts). Amplification conditions were 30 cycles of
94
 
8
 
C for 1 min, 55
 
8
 
C for 2 min, and 72
 
8
 
C for 1 min.
After several generations of breeding onto the BALB/c back-
ground, mice of lines I, B, H (TdtL), U, and V (TdtS) were
crossed with Tdt-deficient C57Bl/6 
 
3 
 
SJL mice (28). Lines I, B,
and H had estimated TdtL transgene copy numbers of 2 or 3, 10–
12, and 5 or 6, respectively. Tdt-deficient mice were identified
using primers Tdta, Tdtb, and Tdtc as described by Gavin and
Bevan (29). To detect the presence of our Tdt transgene on the
homozygous Tdt-deficient background, it was necessary to de-
sign a primer pair to detect endogenous Tdt that anneals to nei-
ther the Tdt knockout construct nor the TdtL/TdtS transgene.
Such a primer pair was obtained by sequencing into the intron
between exons 4 and 5 of mouse genomic Tdt and designing a
primer complementary to the fifth exon of Tdt, primer Ex5-NC-
Tdt: 5
 
9
 
-GCTTCAGAACTTTCTCCATCTTC-3
 
9
 
 to generate a
PCR product in combination with primer Tdta in the fourth
exon of Tdt. This PCR product was cloned and sequenced. A
partial sequence of this intron is available from EMBL/GenBank/
DDBJ under accession no. AF318947. From this intronic
sequence we designed the primer Tdt4-5Intron: 5
 
9
 
-GTAG-
CAAATTCCACTTCTCC-3
 
9
 
. Primer Tdt4-5Intron anneals
from positions 6 through 25 bp immediately downstream of exon
4 of wild-type, endogenous Tdt and produces a product of 200-
bp in length when used in combination with primer Tdta. Three
PCR reactions are performed on TdtS or TdtL Tg mice bred to
the Tdt
 
2
 
/
 
2
 
 background: the presence of the transgene is detected
by a transgene-specific PCR as described previously (primers
IgP-1 and TL-3); the presence of the Neo-inserted Tdt allele is
detected by primers Tdtc and Tdtb; and the presence of the en-
dogenous Tdt allele is detected by primers Tdta and Tdt4-
5Intron. TdtL and TdtS mice were bred for two generations to
Tdt
 
2
 
/
 
2
 
 mice and the second generation was screened by PCR for
the presence of the transgene, the presence of the Neo-Tdt con-
struct, and the absence of endogenous Tdt. All mice were main-
tained in a specific pathogen-free barrier facility in Microisolation
(Lab Products) caging. All experiments and animal procedures
conformed to protocols approved by the University of Alabama
at Birmingham Institutional Animal Care and Use Committee.
 
Reverse Transcription PCR.
 
TdtS and TdtL Tg mRNA were
detected using 5
 
9
 
 primer 1450Tdt and a 3
 
9
 
 primer within either
the J
 
H
 
3 gene segment exon (exJ
 
H
 
3: 5
 
9
 
-CTGCAGAGACAGT-
GACCAGAGT-3
 
9
 
) that lies just downstream of the Tdt cDNA
or a primer within the first exon of C
 
m
 
 (5
 
9
 
 plus 1 C
 
m
 
 FM-1: 5
 
9
 
-
GACATTTGGGAAGGACTGACT-3
 
9
 
; for C
 
m
 
 primer, refer-
ence 30). The product generated from TdtL cDNA when using
1450Tdt and exJ
 
H
 
3 is 580 bp. 1450Tdt and the C
 
m
 
 primer yield a
600-bp product indicating, in 17 out of 18 Tdt Tg lines of either
splice variant, that the mRNA was spliced such that the C
 
m
 
 exon
is juxtaposed with the J
 
H
 
 segments just downstream of the Tdt
cDNA.
Messenger RNA was extracted from whole bone marrow,
spleen, thymus, or fetal liver using the TRI reagent (Molecular
 
Research Center, Inc.). All samples were treated with DNase
(GIBCO BRL) before reverse transcription (RT) to eliminate
genomic DNA contamination. cDNA was synthesized using
avian myeloblastosis virus (AMV) reverse transcriptase (GIBCO
BRL) and PCR was performed as described previously (27) using
primers described above.
 
Imaging of LPS-stimulated Splenocytes and Fetal Liver Cells.
 
Cy-
tocentrifuge smears were made from LPS-activated spleen cells
from adult Tg and non-Tg littermate (LM) mice of each of the
10 TdtL lines at intervals up to 7 d. Fetal liver cells were prepared
and smears made as described previously (27). Smears were dried,
fixed in absolute methanol, and stained for Tdt expression with
rabbit anti-Tdt (Supertechs) developed with an Alexa 488–cou-
pled goat anti–rabbit IgG Ab (Molecular Probes) and rhodamine
isothiocyanate (RITC) goat anti-IgM as described previously
(27). Images were acquired on a Leica DMRB fluorescence mi-
croscope equipped with appropriate filter cubes (Chromatech-
nology) and a C5810 series digital color camera (Hamamatsu
Photonic System) as described previously (30). The fluorescence
intensity of Tdt staining of fetal liver cells from the three TdtL Tg
mice was measured from digital images using the Density Slicing
and Advanced Measurement Modules of OpenLab Imaging Soft-
ware (Improvision Inc.). Fluorescence intensity of Tdt staining
was calculated as the product of mean fluorescence and area and
is expressed as arbitrary units. Confocal microscopy was per-
formed on cytocentrifuge smears of LPS-activated spleen cells us-
ing a confocal laser scanning microscope
 
 
 
(Leica).
 
Sequencing of Ig Gene Rearrangements.
 
Genomic DNA was
prepared from day 16 fetal liver, adult bone marrow, and spleen
of Tdt Tg and LM mice. V
 
H
 
7183 family to J
 
H
 
1–4 gene rearrange-
ments were amplified, cloned, and sequenced as described (27).
DFL16.1-JH1 gene rearrangements were amplified using primers
and conditions as described (31) and sequences with ambiguous
bases in the CDR3 region were discarded. N nucleotide status
was assigned as described previously (27).
 
PC Immunization and T15 Quantitative ELISA.
 
Mice were
immunized with heat-killed 
 
S. pneumoniae
 
, strain R36A. Serum
levels of anti-PC Ab and Ids were quantified by ELISA as de-
scribed previously (27).
 
Results
 
Cloning of Mouse cDNA for TdtL and TdtS.
 
Mouse Tdt
was amplified, cloned, and sequenced from C57Bl/6 thy-
mus cDNA. Initially, a 1.9–2.0-kb Tdt fragment was am-
plified and was found to differ from the Koiwai sequence
by a deletion of 60 bp in the downstream region of the
clone. Primers flanking the deleted region were used to
amplify the “missing piece” needed to generate the long
form of Tdt from C57Bl/6 thymus cDNA. The longer,
much less abundant, of the two fragments amplified was
shown to contain a 60-bp insertion identical to the murine
Tdt sequence published by Koiwai (19). Comparison of
our mouse TdtL sequence to that of Koiwai (sequence data
are available from EMBL/GenBank/DDBJ under accession
no. X04123) and, more recently, Doyen et al. (18) revealed
only one region between nucleotides 1,373 and 1,382
within exon IX in which our sequence differed from both
of these. This region is present in both TdtL and TdtS and
our sequence contains an arginine codon inserted between
1,376 and 1,379. Aa translation of this region from mouse, 
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human, and bovine sequences reveals that the independent
mouse clones (TdtL and TdtS) contain other minor differ-
ences which may be strain dependent (Koiwai, accession
no. X04123 [19], and Doyen et al. [18]).
 
Generation of TdtL Tg Mice.
 
A plasmid construct con-
taining our TdtL cDNA was designed identical to that de-
scribed for TdtS Tg mice (27). 10 lines of TdtL Tg mice
were generated containing the TdtL cDNA under control
of the V
 
H
 
81X promoter and the 
 
m
 
 enhancer, with the C
 
m
 
exons placed downstream to enable mRNA processing.
TdtL Tg mice were identified by PCR and by Southern
blot of genomic tail DNA (Fig. 1 A) and, because of the
60-bp difference in size, could be clearly discriminated
from the TdtS transgene in PCR, Southern blot, and RT-
PCR analyses. TdtL mRNA was detected by transgene-
specific RT-PCR in newborn liver and in adult bone mar-
row, spleen, and thymus (Fig. 1, C and D).
 
TdtL Protein Is Detectable in the Nucleus of Lymphoid
Cells.
 
Because there was no prior evidence for TdtL pro-
tein expression in vivo, we screened our TdtL Tg mouse
lines by immunofluorescent staining of LPS-stimulated
splenocytes, the method that previously yielded the greatest
abundance and most easily detected Tg protein in our TdtS
Tg lines. Using this approach, TdtL protein was detected in
7 of our 10 independent TdtL Tg lines, three of which
(lines I, B, and H) were chosen for detailed study. By im-
munofluorescence microscopy, TdtL Tg B cells appeared
to express TdtL in the nucleus similarly to the nuclear
staining seen in TdtS Tg B cells (line V; Fig. 2). These data
are in direct contrast to in vitro expression data of Bentolila
Figure 1. Southern blot, RT-PCR,
and protein expression from TdtL trans-
gene. (A) Genomic DNA was analyzed
by Southern blot from non-Tg LM,
TdtS, and TdtL Tg mice. The 1.8- and
1.86-kb bands correspond to the TdtS
and TdtL transgenes, respectively. The
4.1-kb band corresponds to a fragment
of endogenous Tdt as seen in the non-
Tg LM. (B) Embryonic day 19 fetal liver
cells from TdtL Tg mouse lines I, B, and
H (from left to right) were stained for m
chains (red) and Tdt (green) in the top
panels with corresponding nuclei re-
vealed with Hoechst 33258 (blue) be-
low. Original magnification indicated by
bar inset. (C) TdtL expression was dem-
onstrated by RT-PCR analysis of TdtL
mRNA from newborn liver. Lanes 1
and 4 are RT-PCR products from TdtL
and non-Tg LM newborn livers. Lane 2
is an RT-negative control product from
liver mRNA. Lane 3 is a PCR product
from a genomic tail DNA template used
as a size control for the RT-PCR prod-
uct. Lane 5 is a template-negative con-
trol. The blot was probed with the 1.8-
kb BamHI fragment. TdtS PCR primers
were 1450Tdt and exJH3. (D) Ethidium
bromide (EtBr)-stained agarose gel of RT-PCR products from bone marrow (BM), spleen (SP), and thymus (THY) of an adult TdtL Tg mouse (lanes
2–4). Lanes 5–7 are corresponding RT-negative controls for each tissue. Lane 1 is a 1-kb ladder size standard (GIBCO BRL). PCR primers were
1450Tdt and 59 plus 1 Cm FM-1.
Figure 2. Immunofluorescence of Tdt Tg splenocytes by fluorescence microscopy. Immunofluorescence of LPS-activated adult spleen B cells from (A)
non-Tg LM, (B) line V (TdtS), (C) line I, (D) line B, and (E) line H (TdtL) Tg mice, stained for cytoplasmic m chains (red) and Tdt (green). All Tg lines
exhibit nuclear staining for Tdt. Original magnification indicated by bar inset. 
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et al. (25) who demonstrated by confocal microscopy that
TdtL was excluded from the nucleus. In our experiments,
the TdtL Tg splenocytes appear to stain more brightly for
cytoplasmic Tdt expression than do TdtS cells, but TdtL is
not excluded from the nucleus in any of our TdtL Tg lines.
Non-Tg LM control splenocytes were negative for Tdt ex-
pression in both the nucleus and the cytoplasm after LPS
stimulation (Fig. 2). Additionally, we screened for TdtL ex-
pression in newborn liver (Fig. 1 B), a tissue in which our
TdtS transgene was expressed whereas endogenous Tdt is
not (27
 
). 
 
We found that TdtL was also expressed in the nu-
cleus of fetal liver cells of TdtL lines B, I, and H, although
there were apparent differences in the levels of expression.
By measuring the mean fluorescence intensity of TdtL
staining by density slicing, we found that H and I expressed
 
two- to threefold higher levels of Tdt than did line B (Fig.
3). These findings opened the possibility that, if functional,
TdtL might affect the development of the adult B cell rep-
ertoire as did
 
 
 
expression of our TdtS transgene.
To confirm that Tg TdtL enters the nucleus of TdtL Tg
B cells, we compared Tdt expression in LPS-stimulated
splenocytes from line V (TdtS) Tg mice to those from line
I (TdtL) Tg mice by confocal microscopy (Fig. 4, B and C,
respectively). Confocal images clearly demonstrate that
TdtL can enter the nucleus of lymphoid cells. Again, Tdt
can be detected in the cytoplasm of LPS-stimulated TdtL
Tg B cells, but Tdt is not excluded from the nucleus. This
is also the first demonstration of TdtL protein expression in
nontransformed mouse B cells. Non-Tg LM splenocytes
do not express detectable levels of nuclear or cytoplasmic
Tdt with or without LPS stimulation (Figs. 2A and 4A),
and also provide a control for the specificity of the rabbit
anti-Tdt Ab. The absence of peripheral expression of Tdt
has been described and is shown previously as a footnote in
the work of Han et al. in agreement with our data (32–34).
 
TdtL Does Not Catalyze N Addition in Fetal Liver but May
Reduce TdtS Activity.
 
Intracellular endogenous Tdt can-
not be detected by immunofluorescence in fetal liver;
however, trace amounts can be detected by Western blot
(Thai, T.-H., and J.F. Kearney, manuscript in preparation).
As a consequence, fetal Ig gene rearrangements are nor-
mally N-less. TdtS Tg mice generated from a construct
similar to the TdtL transgene exhibited N addition in fetal
Ig gene rearrangements (27), so we assayed fetal and new-
born liver of TdtL Tg mice for N addition to Ig gene rear-
rangements (Fig. 5). Of three TdtL Tg mouse lines that
expressed TdtL protein, as demonstrated by immuno-
fluorescence, none displayed significant N addition in fetal
liver. V
 
H
 
7183 Ig rearrangements from TdtL Tg fetal and
newborn livers were identical to those of non-Tg LM mice
with respect to N addition, palindromic (P) nucleotide ad-
dition, and nibbling. Previously published sequences from
the TdtS Tg line V contained adult-like N addition (more
Figure 3. Three independent lines of TdtL mice exhibit different levels
of Tdt expression as determined by measuring the intensity of nuclear im-
munofluorescence. The level of fluorescence of individual fetal liver cells
was calculated as explained in Materials and Methods and is expressed as
arbitrary units on the y axis. The standard deviation expressed as error
bars on each column represents actual differences in the intensity and size
of cell nuclei. Overall, line B stained two- to threefold less than did lines
H and I.
Figure 4. Immunofluorescence of non-Tg TdtS and TdtL splenocytes by fluorescence confocal microscopy. Confocal microscopy of LPS-activated
spleen B cells stained for cytoplasmic m chains (red) and Tdt (green) from (A) non-Tg LM, (B) line V (TdtS), and (C) line I (TdtL) Tg mice. In each
panel the x-slice is shown in the large box, with the corresponding yz and xz sections displayed in the rectangles on the right and bottom, respectively, of
each panel. Nuclear localization of Tg TdtS and TdtL is discernible in B and C, although in C the yellow granular staining indicates that TdtL is also
found in the cytoplasm. Original magnification indicated by bar inset. 
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than 1 nucleotide at this junction) in 90% of V
 
H
 
-D junc-
tions and 45% of D-J
 
H
 
 junctions of V
 
H
 
7183 family H chain
rearrangements as early as day 16 of gestation (27). Strik-
ingly, when we crossed TdtS Tg line V mice with TdtL Tg
line I mice, only 50% of V
 
H
 
-D junctions and 13% of D-J
 
H
 
junctions of V
 
H
 
7183 H chain rearrangements from day 16
fetal liver contained N addition of more than 1 nucleotide,
indicating that expression of TdtL protein may affect TdtS
activity or expression. The average number of N nucle-
otides added per junction was similar between line V and
line V 3 I.
TdtL/TdtS Double Tgs Display More Homology-directed
Joining and Less N Addition in Fetal Liver than do TdtS Tg
Mice. To investigate the possible downregulation of TdtS
activity by TdtL, we examined DFL16.1-JH1 rearrange-
ments from day 16 fetal liver (Table I). D-JH rearrange-
ments allow for unambiguous assignment of N nucleotide
status because we know the definitive boundaries of the
DFL16.1 and JH1 gene segments. N addition occurs in 36%
of the D-JH sequences amplified from TdtS line V fetal
liver, but in two of the TdtL/TdtS double Tg lines (V 3 I
and V 3 H) N addition is only found in 7–10% of D-JH se-
quences (Table I). V 3 B does not exhibit such a striking
reduction most likely because TdtL expression appears to
be two- to threefold less in line B (and also has the highest
copy number, which may interfere with expression) than
in lines I and H. At day 16 of gestation, even in line V, the
N additions were not very long. 10 of 12 D-JH sequences
from line V that contained N addition contained only one
or two N nucleotides. However, if one assesses the number
of sequences that utilize short sequence homologies (based
on the number of overlapping nucleotides that could have
originated from either the D or the JH germline segment),
TdtS line V is strikingly different from the TdtL/TdtS dou-
Figure 5. Ig H chain rearrangements from fetal or neonatal liver genomic DNA. VH7183-JH rearrangements were amplified, cloned, and sequenced
from whole liver of TdtL Tg line B, line H, line I, and corresponding non-Tg LM mice. The ages of the mice at the time of sacrifice were as follows: line
B, newborn (,24 h after birth); line H, newborn; line I, day 18 of gestation; line V 3 I, day 16 of gestation. LM sequences originated from newborn
non-Tg LMs of line B and line H and have been combined in the table. For VH81X (7183.1A) the entire coding sequence is known, but for the remain-
ing VH7183 genes, each VH was truncated after Arg codon 94 (AGA) and any non-V, non-D nucleotides placed in the V/N column. Nucleotides in the
V/N column that likely originated from the V segment (based on repeated occurrence in multiple clones) are in lowercase letters. Parentheses delineate
the boundaries of D–D fusions. P nucleotides are underlined. Nucleotides that may originate from either the germline D or germline JH segments appear
in italic. IF, in frame; RF, reading frame; DBL, double. Amplifications were performed with a JH4 primer. Sequence data are available from EMBL/Gen-
Bank/DDBJ under accession nos. AF318407–447.95 Benedict et al.
ble Tgs. As has been shown previously (35, 36), homology-
directed recombination is a feature of fetal Ig gene rear-
rangement, occurring normally in the absence of Tdt. In
TdtL/TdtS double Tgs, the amount of homology-directed
recombination is consistently intermediate between TdtS
line V alone, which has very little homologously derived
D-JH joining, and the high frequency of homologously de-
rived D-JH joins that occurs in normal fetal liver (35, 36),
or in our TdtL Tg and non-Tg LM mice. This observation
further supports the idea that TdtL is downregulating TdtS
activity. One caveat of these data is that when one amplifies
D-JH rearrangements from fetal liver, recurrent sequences
are found because there is less diversification by which to
verify independent sequences. The numbers in Table I are
based on the total number of sequences we amplified be-
cause it is very likely that many sequences do in fact recur
in independent cells at the level of D-JH joining. However,
we also calculated the frequency of N addition and N-less
short sequence homologies when only distinctly indepen-
dent sequences are counted. In this case, 57% of line VD-
JHs lack N addition and only 29% of those contain short
sequence homologies (4 nucleotide [nt], 2nt, and 1nt com-
bined). In contrast, 59, 86, and 69% of D-JHs from V 3 B,
V 3 I, and V 3 H lacked N addition, respectively. Of
those lacking N addition, 54, 50, and 50% of V 3 B, V 3
I, and V 3 H D-JHs contain short sequence homologies.
Thus, even when repetitive sequences are omitted, the
trend holds true that TdtL and TdtS transgenes together re-
sult in less N addition and more homology-directed re-
combination than does TdtS alone. Furthermore, the aver-
age length of D-JH joins from TdtL/TdtS Tg mice was
three nucleotides shorter than the average length of D-JH
joins from TdtS line V alone. Because we observed previ-
ously that CDR3 lengths from fetal liver of TdtS Tg mice
were not significantly different from those of non-Tg LMs,
it is likely that these differences will be either compensated
by nibbling during VH-D rearrangement or that these
longer junctions will be selected against after VH-D rear-
rangement is complete.
TdtS, but Not TdtL, Restores N Addition in Tdt Knockout
Mice. To exclude the possibility that TdtL is simply not
active in fetal liver because of a microenvironmental re-
quirement, we tested its ability to add N nucleotides in
bone marrow, the usual site of N nucleotide addition in B
cells of adult mice. TdtS or TdtL Tg mice were crossed to
endogenous Tdt-deficient (Tdt2/2) mice (28) for two gen-
erations. First, we confirmed that in the TdtS transgene
lines (U and V), TdtS is sufficient to catalyze N addition to
Ig H chain rearrangements (27) in the absence of endoge-
nous Tdt (Fig. 6). Although fetal CDR3 lengths were
maintained in TdtS fetal liver Ig H chain rearrangements,
CDR3 lengths were increased to adult proportions in
TdtS/Tdt2/2 bone marrow. N addition was also observed
in k and g L chain rearrangements of TdtS/Tdt2/2 bone
marrow (data not shown). VH7183 family Ig H chain gene
rearrangements were amplified from bone marrow of TdtL
Tg mice of lines B, H, and I on the Tdt2/2 background.
The H chain rearrangements isolated from the TdtL/Tdt2/2
mice did not contain N addition (Fig. 6) nor did L chain
rearrangements from TdtL/Tdt2/2 mice contain N addi-
tion (data not shown). Thus, an adult bone marrow con-
text for TdtL expression does not facilitate the addition of
N nucleotides by TdtL.
Tdt Deficiency Increases the T15 Id1 Protective Anti-PC Re-
sponse. The T cell–independent immune response to PC
is dominated by the protective T15 Id Ab, encoded by an
N-less Ig H chain rearrangement (37, 38). The T15 anti-
PC response proved to be an effective functional readout
for TdtS activity in our TdtS Tg mice (27). Because the
premature N addition results in a loss of T15 Abs express-
ing canonical CDR3 joins in TdtS Tg mice, we hypothe-
sized that decreased, or absent, N addition might result in
an increase in T15 Abs in the PC response of Tdt2/2 or
TdtL Tg mice. We immunized Tdt2/2 mice, TdtL/Tdt2/2,
Table I. D-JH Junctions in TdtS, TdtL, and TdtS/TdtL Tg Mice
D-J overlap
Mouse line Total seq  Unique seq Seq with N Seq without N 4nt 2nt 1nt 0nt
n n n(% total) n(% total) n seq (% seq without N)
V-TdtS (n 5 1) 33 28 12(36) 21(64) 5(24) 1(5) 4(19) 11(52)
V 3 B (n 5 2) 28 22 9(32) 19(68) 6(32) 1(5) 6(32) 6(32)
V 3 I (n 5 2) 28 14 2(7) 26(93) 14(54) 3(11) 1(4) 8(31)
V 3 H (n 5 1) 31 13 3(10) 28(90) 17(61) 1(4) 3(11) 7(25)
H-TdtL (n 5 1) 10 5 0(0) 10(100) 6(60) 1(10) 1(10) 2(20)
non-Tg LM (n 5 1) 4 2 0(0) 4(100) 3(75) 1(25) 0(0) 0(0)
Summary of DFL16.1-Jh1 joins from day 16 fetal liver genomic DNA. Sequence (seq) with number (and percentage) that were found to contain N
nucleotide addition ($1nt). In parentheses in the mouse line column is the number of mice from which liver DNA was prepared. 4nt of overlap
indicates possible homology-directed recombination. 0nt indicates no overlap and that homology-directed recombination was not likely used. No
sequences were found that contained an overlap of 3nt. Primary data from which this table was derived are available from EMBL/GenBank/DDBJ
under accession nos. AF318759–768, and AF318771–894.96 Functional Analysis of Tdt Isoforms
TdtS/Tdt1/1, and normal LM (Tdt1/1) mice with a heat-
killed R36A pneumococcal vaccine, as described previ-
ously (27). Table II shows that Tdt2/2 and TdtL/Tdt2/2
mice exhibit higher overall levels of total anti-PC Abs as
well as the T15 and other Id1 Abs in serum ELISA assays of
their anti-PC response. TdtL mice on the BALB/c back-
ground exhibit similar T15 responses to normal BALB/c
mice. These results indicate that the absence of Tdt results
in the generation of more T15 B cells, possibly because the
window of time for their generation is extended. Addition-
ally, the T15 Id requires an aspartic acid residue at position
95 involving the VH-D junction of VHS107.1 Ig H chain
that is encoded by the VHS107.1 segment. TdtL has little
effect on the PC response, regardless of whether endoge-
nous Tdt is present or absent (Table II), in contrast to TdtS
that causes a drastic decrease in the T15 response (27).
Discussion
In this work, we address the role of the two splice vari-
ants of Tdt in vivo. We independently amplified, cloned,
and sequenced TdtS and TdtL cDNA to confirm the ex-
pression of these two variants and used them to help resolve
the contradictions in the literature regarding whether the
long splice variant catalyzes N addition or not (19, 25). The
confirmatory test of a gene’s function is to complement a
defect with that gene, and we have taken advantage of the
Tdt2/2 mouse model to test the function of our TdtS and
TdtL transgenes (28). Our results indicate that TdtL does
not catalyze N addition in vivo, but that TdtS alone is suffi-
cient to complement the loss of the endogenous Tdt gene.
That the failure of TdtL to catalyze N addition may be par-
tially due to its inability to translocate to the nucleus (25) is
called into question by our data, which clearly show TdtL
expression in the nucleus. This is an important point be-
cause any physiological role for TdtL in V(D)J recombina-
tion obviously requires its presence in the nucleus.
The literature contains many examples of genes for
which mRNA transcripts can be variably spliced, resulting
in structurally and functionally distinct protein products.
Several immunologically relevant genes have been de-
scribed for which multiple mRNA splice variants have
been isolated. In the case of Tdt, the inclusion or exclusion
of a single exon results in two splice variants. Among the
nuclear factor (NF)-kB/IkB (39), Oct (40), and Ikaros (41)
transcription factors, and the Bcl-2 survival gene family
(42), ranges of 2–10 alternatively spliced mRNA products
have been described, which carry out distinct roles in regu-
Figure 6. Ig H chain rearrangements from bone marrow genomic DNA of TdtS/Tdt2/2 or TdtL/Tdt2/2 mice. VH7183-JH rearrangements were am-
plified, cloned, and sequenced from whole bone marrow of TdtS Tg lines U, V (26) for TdtL Tg lines B, H, or I adult mice on an endogenous Tdt-
deficient background. Thus, in this figure the non-Tg LM is actually a Tdt2/2 mouse. All mice were at least 8 wk of age at time of killing. Some ampli-
fications were performed with a mixture of JH primers, others with only a single JH primer. IF, in frame; RF, reading frame. Sequence data are available
from EMBL/GenBank/DDBJ under accession nos. AF31448–488.97 Benedict et al.
lation of cellular pathways and functions. This regulation is
usually achieved by altering, temporally or proportionately,
levels of various splice products generated. For some differ-
entially spliced genes described, distinct functions have
been identified for the protein products of the correspon-
dent mRNA splice variants. For Tdt, the specific function
of the TdtL splice variant has not been revealed.
Tdt is a unique protein initially described decades ago; its
enzymatic function was first studied biochemically (43),
and a biological function was later discovered in lymphoid
cells (3). More recently, two splice variants for Tdt were
described (18). The reported full-length sequence of one
(of two) original mouse Tdt cDNA clones isolated from a
mouse lymphoma RL-12 library turned out to be the TdtL
splice variant (19). Terminal transferase activity was clearly
demonstrated in lysates from COS cells that had been
transfected with the original TdtL clone. However, recent
testing of one of the original TdtL clones, in parallel with
an independently isolated TdtL clone, indicated that TdtL
is excluded from the nucleus (25). Although this discrep-
ancy between the two studies might be explained by the
putative failure of TdtL to translocate to the nucleus, results
with lysates from COS cell transfectants cannot. In these
assays, Bentolila et al. (25) reported that the two TdtL
clones conferred negligible activity and were at least 10–15
times less efficient than the TdtS clone. This seemingly
contradicts the original Koiwai et al. (19) COS cell trans-
fection data, although a direct comparison of all cDNAs
used would be required to draw any useful conclusions
about the function of TdtL. Thus, to date, results regarding
the function of TdtL are contradictory, inconclusive, and
limited to in vitro assays of transfected cells.
Therefore, to elucidate a possible function for TdtL and
ascertain unequivocally in vivo whether TdtL can add N
nucleotides to rearranging Ig or TCR genes, we generated
TdtL Tg mice. Using a similar construct bearing TdtS
cDNA, we demonstrated previously nuclear expression of
TdtS protein and N addition to Ig rearrangements (27).
Consequently, this construct is well suited for testing the
expression and capacity for N addition of TdtL. Nuclear
TdtL expression  in mouse B cells was demonstrated in
LPS-stimulated splenocytes of seven independent TdtL Tg
lines, similar to the pattern of expression in spleen cells
from our TdtS Tg mice. This is the first demonstration of
TdtL protein expression in mouse B cells and in a nuclear
location. TdtL appears to be retained in the cytoplasm at a
higher level than TdtS protein in our LPS-cultured cells,
but TdtL is clearly translocated to the nucleus of B cells,
where it presumably has access to rearranging Ig genes.
To determine whether nuclear-expressed TdtL can add
N regions to rearranging Ig genes in vivo, we sequenced Ig
gene rearrangements from adult bone marrow of TdtL Tg
mice crossed with endogenous Tdt2/2 mice. Ig H and L
chain rearrangements from both Tdt2/2and TdtL/Tdt2/2
mice contained no N addition; however, TdtS/Tdt2/2 Ig
H and L chain rearrangements contained convincing N ad-
dition. Thus, TdtL was incapable of adding N regions
when it was the only splice variant of Tdt available. These
results have also been corroborated by primer extension as-
says in vitro as a measure of Tdt catalytic activity (Thai,
T.-H., and J.F. Kearney, manuscript in preparation). How-
ever, in Tdt Tg mice, expression of TdtL in conjunction
with TdtS resulted in a decrease in N addition in compari-
son to N addition catalyzed by TdtS alone. This effect of
TdtL/TdtS Tg coexpression was observed in complete H
chain rearrangements and was further verified in D-JH rear-
rangements from three independent crosses of TdtL Tg
with TdtS Tg mice. Several possible mechanisms for a
Table II. Anti-PC Responses of TdtL, TdtS, and Tdt2/2
Serum Abs
Genotype Mice IgM PC TC68* TC139* AB1.2* GB4.10*
n
mg/ml
(log 10 SD)
mg/ml
(log 10 SD)
mg/ml
(log 10 SD)
mg/ml
(log 10 SD)
mg/ml
(log 10 SD)
mg/ml
(log 10 SD)
Tdt2/2 20 477.8 (2.5) 149.3 (2.0) 159.3 (1.9) 120.8 (2.0) 121.8 (2.0) 162.8 (2.1)
TdtL I1/Tdt2/2 5 475.3 (2.3) 127.5 (1.6) 140.4 (1.7) 109.1 (1.5) 119.7 (1.4) 148.9 (1.7)
Tdt1/1 13 414.7 (2.2)  83.6 (1.6) 92.9 (1.8) 74.3 (1.7) 79.7 (1.7) 86.4 (1.7)
TdtL I1/Tdt1/1 11 437.5 (2.1) 79.9 (1.7) 81.0 (1.8) 60.6 (1.6)  60.5 (1.7) 77.0 (1.9)
TdtS T1/Tdt1/1‡ 5 416.8 (2.2) 40.0 (1.3) 38.4 (1.9) 20.4 (1.2) 20.0 (1.3) 22.5 (1.4)
TdtS V1/Tdt1/1§  5 426 (1.3) 178 (1.7) 160 (1.8) ND 19 (1.1) 15 (0.95)
Adult mice of each genotype were immunized with heat-killed R36A. Serum anti-PC and Id (*) titers were measured by quantitative ELISA as de-
scribed previously (reference 27). Each column represents the amount of total serum IgM, total anti-PC antibody (mg/ml), and in the columns
marked (*) serum antibody, in mg/ml detected by the following Id markers. TC68 is specific for all VHS107.1 heavy chains; TC139 is specific for
Vk22, the L chain expressed by T15 Id1 Ab. AB1.2 is specific for the T15 CDR3-associated Id; and GB4.10 is specific for the T15 D-JH junction
Id. Values are given as means of each group tested.
‡Values for the line T(TdtS) on the same background as line I mice in this experiment.
§The values for line V(TdtS) on a BALB/c background from reference 27.98 Functional Analysis of Tdt Isoforms
downregulation of N addition can be postulated. For ex-
ample, there may be competition between the two proteins
for binding to DNA and nucleotides. The formation of a
TdtS–TdtL complex could inactivate TdtS or inhibit TdtS
translocation to the nucleus. Alternatively, the reduced N
addition observed may be the result of exonuclease activity
which is associated with the TdtL isoform (Thai, T.-H.,
and J.F. Kearney, manuscript in preparation).
We have shown previously that premature expression of
TdtS has functional consequences that alter the adult anti-
PC Ab repertoire in BALB/c mice (27). Expression of
TdtS in fetal life increased diversity in the fetal repertoire
and concomitantly decreased the window of opportunity
for generation of important germline-encoded specificities
such as T15, the protective Id in the immune response
against virulent pathogens like S. pneumoniae. It follows that
the T15 response provides a readout for repertoire alter-
ations associated with TdtL activity or a Tdt2/2 phenotype.
Immune responses against complex Ags that stimulate large
polyclonal B cell responses appear to be intact in Tdt2/2
mice (44), but T cell–independent, canonical responses in
B cells have not been examined previously in Tdt-deficient
mice. Here, we demonstrate that there is a phenotypic al-
teration in the immune response of Tdt2/2 mice when im-
munized with heat-killed S. pneumoniae. In contrast to
TdtS mice that exhibit normal or reduced levels of anti-PC
Abs (Table II) comprised mostly of nonprotective, non-
T15 clones (27), Tdt2/2 mice exhibit higher than normal
levels of both anti-PC Abs and T15 Id1 Abs. This is the
first demonstration of a convincing phenotypic alteration in
the B cell repertoire of Tdt2/2 mice. Several explanations
for this phenotype are possible: (a) the adult B cell reper-
toire may be less diverse in general (more fetal-like) be-
cause of decreased junctional diversity caused by a lack of
Tdt; (b) the window of opportunity for generation of germ-
line-encoded Ids may be extended into adult life, perhaps
indefinitely, by the lack of Tdt; and (c) the restriction of
CDR3 lengths required to produce functional Abs may
lead to the generation or selection of more clones in which
nibbling is reduced in the absence of Tdt. In each case,
there is an increase in the likelihood of preserving aa at the
VH-D and D-JH critical to forming the T15 Id.
The TdtL mice produce anti-PC and anti-T15 Abs at
levels greater than those found in non-Tg LM mice.
CDR3 lengths are restricted in Ig rearrangements, indicat-
ing that junctional diversity must be regulated. This regula-
tion may be accomplished during V(D)J recombination, by
selection of optimal H/L chain pairing, by selection after
the Ig goes to the cell surface, or by a combination of these.
We propose that regulation of CDR3 length is accom-
plished in part during V(D)J recombination by the activities
of both TdtS and TdtL.
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